 Authors who publish in CMH have an option to make their manuscripts available immediately after acceptance. These “Just Accepted” manuscripts have already been peer-reviewed and approved for publication, but have not yet been proofread or formatted for publication. When authors choose to take advantage of this CMH service, their papers are uploaded as PDF files with an abstract to the CMHwebsite and available right away to contribute to the research community. When the “Just Accepted” paper is uploaded, this is considered the official publication date, but the “Just Accepted” paper is not considered the final paper of record because the editing process may identify errors to be corrected. Authors should indicate whether they would like their manuscript uploaded as a “Just Accepted” file when they first submit their paper. It is not possible to change this decision in the middle of the technical editing and formatting process. A “Just Accepted” manuscript should be cited as an online journal article. To cite a “Just Accepted” manuscript when writing for CMH, follow the guidelines in How to Format the References in the Instructions for Authors section. |
||
> Browse Articles > Accepted Articles 
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
